148 related articles for article (PubMed ID: 32556098)
1. Engrailed Homeobox 1 and Cytokeratin 19 Are Independent Diagnostic Markers of Eccrine Porocarcinoma and Distinguish It From Squamous Cell Carcinoma.
Miura K; Akashi T; Namiki T; Hishima T; Bae Y; Sakurai U; Murano K; Shiraishi J; Warabi M; Tanizawa T; Tanaka M; Bhunchet E; Kumagai J; Ayabe S; Sekiya T; Ando N; Shintaku H; Kinowaki Y; Tomii S; Kirimura S; Kayamori K; Yamamoto K; Ito T; Eishi Y
Am J Clin Pathol; 2020 Sep; 154(4):499-509. PubMed ID: 32556098
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma.
Mahalingam M; Richards JE; Selim MA; Muzikansky A; Hoang MP
Hum Pathol; 2012 Aug; 43(8):1265-72. PubMed ID: 22285043
[TBL] [Abstract][Full Text] [Related]
4. Porocarcinoma: an exceedingly rare tumor or a tumor eclipse phenomenon?
Urso C
Hum Pathol; 2013 Mar; 44(3):448-9. PubMed ID: 23332868
[No Abstract] [Full Text] [Related]
5. Porocarcinoma: an exceedingly rare tumor or a tumor eclipse phenomenon?--Reply.
Mahalingam M; Hoang MP
Hum Pathol; 2013 Mar; 44(3):449. PubMed ID: 23290010
[No Abstract] [Full Text] [Related]
6. CK7 expression in primary cutaneous squamous cell carcinoma.
Pulitzer M; Desman G; Busam KJ
J Cutan Pathol; 2010 Sep; 37(9):966-72. PubMed ID: 20528966
[TBL] [Abstract][Full Text] [Related]
7. Homeobox transcriptional factor engrailed homeobox 1 is expressed specifically in normal and neoplastic sweat gland cells.
Miura K; Akashi T; Ando N; Ayabe S; Kayamori K; Namiki T; Eishi Y
Histopathology; 2018 Jun; 72(7):1199-1208. PubMed ID: 29436004
[TBL] [Abstract][Full Text] [Related]
8. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
9. A case of eccrine porocarcinoma: A treacherous mimic and diagnostic challenge.
Das D; Datta C; Chatterjee U; De A
Indian J Pathol Microbiol; 2021; 64(1):186-188. PubMed ID: 33433439
[TBL] [Abstract][Full Text] [Related]
10. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
Boussahmain C; Mochel MC; Hoang MP
Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
[TBL] [Abstract][Full Text] [Related]
11. Eccrine porocarcinoma: case report and review of the literature.
Grieco M; Simonacci F; Grignaffini E; Ricci R; Raposio E
G Ital Dermatol Venereol; 2020 Aug; 155(4):500-504. PubMed ID: 33050682
[TBL] [Abstract][Full Text] [Related]
12. [A case report of eccrine porocarcinoma].
Fumo G; Piras V; Pilloni L; Ferreli C; Pau M
Clin Ter; 2015; 166(4):e273-5. PubMed ID: 26378762
[TBL] [Abstract][Full Text] [Related]
13. A Rare Case of Eccrine Porocarcinoma of the Eyelid.
Chua PY; Cornish KS; Stenhouse G; Barras CW
Semin Ophthalmol; 2015; 30(5-6):443-5. PubMed ID: 24576261
[TBL] [Abstract][Full Text] [Related]
14. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
15. Eccrine porocarcinoma: a report of 2 cases and review of the literature.
Nguyen A; Nguyen AV
Cutis; 2014 Jan; 93(1):43-6. PubMed ID: 24505584
[TBL] [Abstract][Full Text] [Related]
16. [Primary eccrine porocarcinoma: a clinicopathological study of 50 cases].
Skowron F; Poulhalon N; Balme B; Touzet S; Thomas L
Ann Dermatol Venereol; 2014 Apr; 141(4):258-64. PubMed ID: 24703639
[TBL] [Abstract][Full Text] [Related]
17. Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient.
Gerber PA; Schulte KW; Ruzicka T; Bruch-Gerharz D
Dermatology; 2008; 216(3):229-33. PubMed ID: 18182815
[TBL] [Abstract][Full Text] [Related]
18. Eccrine porocarcinoma presenting as a recurrent wart.
Torbeck R; Fazio J; Lee JB; Trufant J
Cutis; 2019 Mar; 103(3):166-168. PubMed ID: 31039224
[TBL] [Abstract][Full Text] [Related]
19. Eccrine porocarcinoma shares dermoscopic characteristics with eccrine poroma: A report of three cases and review of the published work.
Edamitsu T; Minagawa A; Koga H; Uhara H; Okuyama R
J Dermatol; 2016 Mar; 43(3):332-5. PubMed ID: 26333057
[TBL] [Abstract][Full Text] [Related]
20. BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error.
Afshar M; Deroide F; Robson A
J Cutan Pathol; 2013 Feb; 40(2):259-64. PubMed ID: 23194306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
